Erythropoietin with Retrobulbar Administration Protects Retinal Ganglion Cells from Acute Elevated Intraocular Pressure in Rats

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Ocular Pharmacology and Therapeutics

• Publication date

  2008-09-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/jop.2008.0021PMID 18788995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro

  2006influential reference
• Erythropoietin protects from axotomy‐induced degeneration of retinal ganglion cells by activating ERK‐1/‐2

  2005cited by this paper
• Intravitreal Administration of Erythropoietin and Preservation of Retinal Ganglion Cells in an Experimental Rat Model of Glaucoma

  2005cited by this paper
• Apoptosis in acute and chronic neurological disorders.

  2004cited by this paper
• Erythropoietin and the nervous system.

  2004cited by this paper
• Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease

  2004cited by this paper
• Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation.

  2003cited by this paper
• Hypoxia rapidly activates HIF-3alpha mRNA expression.

  2003cited by this paper
• Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity

  2003cited by this paper
• Hypoxia rapidly activates HIF‐3α mRNA expression

  2003cited by this paper
• Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability

  2003cited by this paper
• Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.

  2003cited by this paper
• Apaf-1, Bcl-xL, Cytochrome c, and Caspase-9 Form the Critical Elements for Cerebral Vascular Protection by Erythropoietin

  2003cited by this paper
• Angiogenesis and Plasticity: Role of Erythropoietin in Vascular Systems

  2002cited by this paper
• HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration

  2002cited by this paper
• Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases

  2002cited by this paper
• Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury

  2002cited by this paper
• Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage

  2002cited by this paper
• Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial

  2002cited by this paper
• Erythropoietin and VEGF exhibit equal angiogenic potential.

  2002cited by this paper
• Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up‐regulating Bcl‐xL expression

  2002cited by this paper
• Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

  2001cited by this paper
• Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades

  2001cited by this paper
• Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades.

  2001cited by this paper
• Erythropoietin gene expression in different areas of the developing human central nervous system.

  2000cited by this paper
• Neurons and astrocytes express EPO mRNA: Oxygen‐sensing mechanisms that involve the redox‐state of the brain

  2000cited by this paper
• Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation.

  2000cited by this paper
• Brain-Derived Neurotrophic Factor-Mediated Neuroprotection of Adult Rat Retinal Ganglion Cells In Vivo Does Not Exclusively Depend on Phosphatidyl-Inositol-3′-Kinase/Protein Kinase B Signaling

  2000cited by this paper
• Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.

  2000influential reference
• Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production.

  1999cited by this paper
• A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice

  1999cited by this paper
• Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects*

  1998cited by this paper
• In vivo evidence that erythropoietin protects neurons from ischemic damage.

  1998cited by this paper
• Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death.

  1996cited by this paper
• Localization of specific erythropoietin binding sites in defined areas of the mouse brain.

  1995cited by this paper

• Nanomedicine in ophthalmology: conquering anatomical barriers and enhancing therapeutic efficacy.

  2025cites this paper
• Topical Administration of Mucoadhesive Liposomes-Epoetin-β for Targeting the Ocular Posterior Segment.

  2025cites this paper
• Erythropoietin in Glaucoma: From Mechanism to Therapy

  2023cites this paper
• The Latest Evidence of Erythropoietin in the Treatment of Glaucoma

  2022cites this paper
• Erythropoietin in Optic Neuropathies: Current Future Strategies for Optic Nerve Protection and Repair

  2022influential citation
• Use of erythropoietin in ophthalmology: a review.

  2021cites this paper
• New nanoparticles for topical ocular delivery of erythropoietin.

  2020cites this paper
• Neuroprotection in Glaucoma – Is Erythropoietin the Solution?

  2020cites this paper
• Characterization of Retinal Ganglion Cell and Optic Nerve Phenotypes Caused by Sustained Intracranial Pressure Elevation in Mice

  2018cites this paper
• Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.

  2018cites this paper
• The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration

  2018cites this paper
• Neuroprotection in glaucoma: recent advances and clinical translation

  2018cites this paper
• Functional and Structural Effects of Erythropoietin Subconjunctival Administration in Glaucomatous Animals

  2018cites this paper
• Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea, and sclera

  2017cites this paper
• Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection

  2017cites this paper
• Revisiting the role of erythropoietin for treatment of ocular disorders

  2016cites this paper
• Ocular Erythropoietin Penetration after Subconjunctival Administration in Glaucomatous Rats

  2016cites this paper
• Natural compounds and retinal ganglion cell neuroprotection.

  2015cites this paper
• Alternative route for erythropoietin ocular administration

  2013cites this paper
• Diosmin Alleviates Retinal Edema by Protecting the Blood-Retinal Barrier and Reducing Retinal Vascular Permeability during Ischemia/Reperfusion Injury

  2013influential citation
• Diosmin Protects Rat Retina from Ischemia/Reperfusion Injury

  2012cites this paper
• Erythropoietin: New Directions for the Nervous System

  2012cites this paper
• Erythropoietin promotes axonal regeneration after optic nerve crush in vivo by inhibition of RhoA/ROCK signaling pathway.

  2012cites this paper
• Oxygen sensing mechanisms in retinal vascular development and disease

  2012cites this paper
• The effects of erythropoietin on RhoA/Rho-associated kinase expression in rat retinal explants cultured with glutamate.

  2012cites this paper
• Oxygen Sensing in Retinal Health and Disease

  2011cites this paper
• Selection of Drug Delivery Approaches for the Back of the Eye: Opportunities and Unmet Needs

  2011cites this paper
• Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus

  2011cites this paper
• Diabetes mellitus: channeling care through cellular discovery.

  2010cites this paper
• ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.

  2010cites this paper
• Oxidative stress: Biomarkers and novel therapeutic pathways

  2010cites this paper
• Erythropoietin schützt retinale Ganglienzellen und die Sehfunktion nach Ischämie und Sehnervkompression im Rattenmodell

  2010cites this paper
• Novel Strategies for Neurovascular Longevity During Aging

  2010cites this paper
• Erythropoietin schützt retinale Ganglienzellen und die Sehfunktion nach Ischämie und Sehnervkom- pression im Rattenmodell

  2010cites this paper
• [Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression].

  2010cites this paper
• New strategies for Alzheimer disease and cognitive impairment

  2009cites this paper
• The Vitamin Nicotinamide: Translating Nutrition into Clinical Care

  2009cites this paper
• Erythropoietin, Forkhead Proteins, and Oxidative Injury: Biomarkers and Biology

  2009cites this paper